A high dosage influenza vaccine induced significantly more neuraminidase antibody than standard vaccine among elderly subjects
Open accessThe DOI matches its Crossref record.
Abstract
Antibody to the neuraminidase (NA) antigen of influenza viruses has been shown to correlate with immunity to influenza in humans and animal models. In a previous report, we showed that an inactivated influenza vaccine containing 60 μg of the hemagglutinin of each strain induced significantly more serum anti-HA antibody among elderly persons than did the standard vaccine containing 15 ug of the HA of each component. We developed a lectin-based assay for anti-NA antibody and used it to measure anti-NA antibody responses among subjects who had participated in that study. The high dosage vaccine contained eight times as much NA activity as the standard vaccine and induced a significantly higher frequency of antibody responses and higher mean postvaccination anti-NA titers to the N1 and N2 of the A/H1N1 and A/H3N2 viruses in the vaccines than did the standard vaccine. Ensuring an increased antibody response to the NA antigen in inactivated influenza virus vaccines should increase the protection against influenza. An increased quantity of the NA antigen in the vaccine will ensure an increased response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
NAction! How Can Neuraminidase-Based Immunity Contribute to Better Influenza Virus Vaccines?
Krammer, F., Fouchier, R. A. M., Eichelberger, M. C., Webby, R. J., Shaw-Saliba, K., Wan, H., Wilson, P. C., Compans, R. W., Skountzou, I., & Monto, A. S. (2018) · mBio · doi:10.1128/mbio.02332-17 · Cited by 288
Couch, R. B., Atmar, R. L., Franco, L. M., Quarles, J. M., Wells, J., Arden, N., Niño, D., & Belmont, J. W. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis935 · Cited by 280
Self-citationDiscordant antigenic drift of neuraminidase and hemagglutinin in H1N1 and H3N2 influenza viruses
Sandbulte, M. R., Westgeest, K. B., Gao, J., Xu, X., Klimov, A. I., Russell, C. A., Burke, D. F., Smith, D. J., Fouchier, R. A. M., & Eichelberger, M. C. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113801108 · Cited by 261
Immunosenescence: influenza vaccination and the elderly
Haq, K., & McElhaney, J. E. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.03.008 · Cited by 256
“The HD SVV demonstrated superior efficacy over SD in large randomized clinical trials for the prevention of influenza A/H3N2 illness in older adults [24] and confirmed safety and improved immunogenicity [25,26].”
MethodWilkinson, K., Wei, Y., Szwajcer, A., Rabbani, R., Zarychanski, R., Abou-Setta, A. M., & Mahmud, S. M. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.03.092 · Cited by 173
Metadata
- Authors
- Cate, T. R., Rayford, Y., Niño, D., Winokur, P., Brady, R., Belshe, R., Chen, W., Atmar, R. L., & Couch, R. B.
- Venue
- Vaccine
- Publisher
- Elsevier BV
- Published
- 2010-02
- Volume
- 28
- Issue
- 9
- Pages
- 2076-2079
- ISSN
- 0264-410X (ISSN-L)
- OpenAlex
- W1965540493
- Cited by
- 127
- References
- 0
- FWCI
- 5.35
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A high dosage influenza vaccine induced significantly more neuraminidase antibody than standard vaccine among elderly subjects. https://app.cochat.ai/papers/10.1016/j.vaccine.2009.12.041
- The paper
- Cate, T. R., Rayford, Y., Niño, D., Winokur, P., Brady, R., Belshe, R., Chen, W., Atmar, R. L., & Couch, R. B. (2010). A high dosage influenza vaccine induced significantly more neuraminidase antibody than standard vaccine among elderly subjects. Vaccine. https://doi.org/10.1016/j.vaccine.2009.12.041
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.